Phibro Animal Health Corporation reported Revenue growth of 4.4% year on year in the fourth quarter 2025, to $ 396.75 millions, this is lower than Phibro Animal Health Corporation's recent average Revenue growth of 6.97%.
Looking into fourth quarter 2025 results within Major Pharmaceutical Preparations industry 87 other companies have achieved higher Revenue growth. While Phibro Animal Health Corporation' s Revenue increase of 4.4% ranks overall at the positon no. 1599 in the fourth quarter 2025.
Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025
Phibro Animal Health's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
19.03 %
1.79 %
-11.79 %
(Dec 31 2024)
PAHC's IV. Quarter Q/Q Revenue Comment
Phibro Animal Health Corporation achieved in the IV. Quarter 2025 above company average sequential Revenue growth of 3.68%, to $ 396.75 millions, from $382.68 millions in the third quarter.
Within Major Pharmaceutical Preparations industry 72 other companies have achieved higher Revenue quarter on quarter growth. While Phibro Animal Health's Revenue growth quarter on quarter, overall rank is 1243.
Phibro Animal Health Corporation achieved in the IV. Quarter 2025 above company average sequential Revenue growth of 3.68%, to $ 396.75 millions, from $382.68 millions in the third quarter.
Within Major Pharmaceutical Preparations industry 72 other companies have achieved higher Revenue quarter on quarter growth. While Phibro Animal Health's Revenue growth quarter on quarter, overall rank is 1243.
Phibro Animal Health's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 1,516.86
$ 1,500.12
$ 1,465.02
$ 1,400.23
$ 1,295.94
Y / Y Revenue Growth (TTM)
17.05 %
26.05 %
32.57 %
33.88 %
27.42 %
Year on Year Revenue Growth Overall
Ranking
# 603
# 803
# 100
# 1306
# 1564
Seqeuential Revenue Change (TTM)
1.12 %
2.4 %
4.63 %
8.05 %
8.9 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 1599
# 1639
# 196
# 1741
# 1790
Cumulative Revenue growth Comment
Assuming the Phibro Animal Health's fiscal year would have ended in Jun 30 2026, Phibro Animal Health would have reprted above average annual Revenue increase of 17.05% year on year, of $ 1,517 millions. This marks a slow-down of the companys growth trends and from the 26.05% improvement in Mar 31 2026.
In the Healthcare sector 129 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 603, from total ranking in previous quarter at 803.
Assuming the Phibro Animal Health's fiscal year would have ended in Jun 30 2026, Phibro Animal Health would have reprted above average annual Revenue increase of 17.05% year on year, of $ 1,517 millions. This marks a slow-down of the companys growth trends and from the 26.05% improvement in Mar 31 2026.
In the Healthcare sector 129 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 603, from total ranking in previous quarter at 803.
About Phibro Animal Health Revenue Growth Rates (PAHC), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
7.54%